These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 9625586)
1. Factor V Leiden mutation does not account for central venous catheter-related thrombosis. Riordan M; Weiden PL Am J Hematol; 1998 Jun; 58(2):150-2. PubMed ID: 9625586 [TBL] [Abstract][Full Text] [Related]
2. The contribution of factor V Leiden and prothrombin G20210A mutation to the risk of central venous catheter-related thrombosis. Van Rooden CJ; Rosendaal FR; Meinders AE; Van Oostayen JA; Van Der Meer FJ; Huisman MV Haematologica; 2004 Feb; 89(2):201-6. PubMed ID: 15003896 [TBL] [Abstract][Full Text] [Related]
3. Factor V Leiden in central venous catheter-associated thrombosis. Fijnheer R; Paijmans B; Verdonck LF; Nieuwenhuis HK; Roest M; Dekker AW Br J Haematol; 2002 Jul; 118(1):267-70. PubMed ID: 12100159 [TBL] [Abstract][Full Text] [Related]
4. Resistance to activated protein C (APC): mutation at Arg506 of coagulation factor V and vascular access thrombosis in haemodialysis patients. Födinger M; Mannhalter C; Pabinger I; Koizar D; Rintelen C; Hörl WH; Sunder-Plassmann G Nephrol Dial Transplant; 1996 Apr; 11(4):668-72. PubMed ID: 8671856 [TBL] [Abstract][Full Text] [Related]
5. Factor V Leiden, protein C, and lipoprotein (a) in catheter-related thrombosis in childhood: a prospective study. Nowak-Göttl U; Dübbers A; Kececioglu D; Koch HG; Kotthoff S; Runde J; Vielhaber H J Pediatr; 1997 Oct; 131(4):608-12. PubMed ID: 9386668 [TBL] [Abstract][Full Text] [Related]
6. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation. De Stefano V; Martinelli I; Mannucci PM; Paciaroni K; Chiusolo P; Casorelli I; Rossi E; Leone G N Engl J Med; 1999 Sep; 341(11):801-6. PubMed ID: 10477778 [TBL] [Abstract][Full Text] [Related]
7. Elevated levels of D-dimer and fragment 1+2 upon central venous catheter insertion and factor V Leiden predict subclavian vein thrombosis. Jansen FH; van der Straaten HM; Roest M; Haas F; de Groot PG; Fijnheer R Haematologica; 2005 Apr; 90(4):499-504. PubMed ID: 15820946 [TBL] [Abstract][Full Text] [Related]
8. Prevalence of inherited prothrombotic abnormalities and central venous catheter-related thrombosis in haematopoietic stem cell transplants recipients. Abdelkefi A; Ben Romdhane N; Kriaa A; Chelli M; Torjman L; Ladeb S; Ben Othman T; Lakhal A; Guermazi S; Ben Hassen A; Ladeb F; Ben Abdeladhim A Bone Marrow Transplant; 2005 Nov; 36(10):885-9. PubMed ID: 16151418 [TBL] [Abstract][Full Text] [Related]
9. Probability of recurrence of thrombosis in patients with and without factor V Leiden. Rintelen C; Pabinger I; Knöbl P; Lechner K; Mannhalter C Thromb Haemost; 1996 Feb; 75(2):229-32. PubMed ID: 8815565 [TBL] [Abstract][Full Text] [Related]
10. Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective. Price DT; Ridker PM Ann Intern Med; 1997 Nov; 127(10):895-903. PubMed ID: 9382368 [TBL] [Abstract][Full Text] [Related]
11. Risk of thrombosis and infections of central venous catheters and totally implanted access ports in patients treated for cancer. Beckers MM; Ruven HJ; Seldenrijk CA; Prins MH; Biesma DH Thromb Res; 2010 Apr; 125(4):318-21. PubMed ID: 19640573 [TBL] [Abstract][Full Text] [Related]
12. Elevated levels of D-dimer and fragment 1+2 upon central venous catheter insertion and factor V Leiden predict subclavian vein thrombosis. Lee A Haematologica; 2005 Apr; 90(4):437. PubMed ID: 15820933 [TBL] [Abstract][Full Text] [Related]
13. Detection of factor V Leiden in Thai patients with venous thrombosis. Prayoonwiwat W; Arnutti P; Hiyoshi M; Nathalang O; Suwanasophon C; Kokaseam R; Krutvecho T; Tatsumi N Asian Pac J Allergy Immunol; 2000 Jun; 18(2):105-8. PubMed ID: 10928623 [TBL] [Abstract][Full Text] [Related]
15. The risk of venous thromboembolism in family members with mutations in the genes of factor V or prothrombin or both. Martinelli I; Bucciarelli P; Margaglione M; De Stefano V; Castaman G; Mannucci PM Br J Haematol; 2000 Dec; 111(4):1223-9. PubMed ID: 11167765 [TBL] [Abstract][Full Text] [Related]
16. Factor V Leiden mutation in cerebral venous thrombosis. Zuber M; Toulon P; Marnet L; Mas JL Stroke; 1996 Oct; 27(10):1721-3. PubMed ID: 8841317 [TBL] [Abstract][Full Text] [Related]
17. The factor V Leiden mutation and risk of renal vein thrombosis in patients with nephrotic syndrome. Irish AB Nephrol Dial Transplant; 1997 Aug; 12(8):1680-3. PubMed ID: 9269648 [TBL] [Abstract][Full Text] [Related]
18. Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A. Lijfering WM; Middeldorp S; Veeger NJ; Hamulyák K; Prins MH; Büller HR; van der Meer J Circulation; 2010 Apr; 121(15):1706-12. PubMed ID: 20368522 [TBL] [Abstract][Full Text] [Related]
19. Relation of factor V Leiden genotype to risk for acute deep venous thrombosis after joint replacement surgery. Ryan DH; Crowther MA; Ginsberg JS; Francis CW Ann Intern Med; 1998 Feb; 128(4):270-6. PubMed ID: 9471929 [TBL] [Abstract][Full Text] [Related]
20. The factor V Leiden mutation increases the risk of venous thrombosis in patients with inflammatory bowel disease. Liebman HA; Kashani N; Sutherland D; McGehee W; Kam AL Gastroenterology; 1998 Oct; 115(4):830-4. PubMed ID: 9753484 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]